Teresa Santiago-Sim1, Xiaoqian Fang1, Morgan L Hennessy1, Stephen V Nalbach1, Steven R DePalma1, Ming Sum Lee1, Steven C Greenway1, Barbara McDonough1, Georgene W Hergenroeder1, Kyla J Patek1, Sarah M Colosimo1, Krista J Qualmann1, John P Hagan1, Dianna M Milewicz1, Calum A MacRae1, Susan M Dymecki1, Christine E Seidman1, J G Seidman1, Dong H Kim2. 1. From the Department of Neurosurgery (T.S.-S., X.F., G.W.H., K.J.P., S.M.C., K.J.Q., J.P.H., D.H.K.) and Division of Medical Genetics, Department of Internal Medicine (D.M.M.), The University of Texas Medical School at Houston; Department of Genetics, Harvard Medical School, Boston, MA (M.L.H., S.V.N., S.R.D., S.C.G., B.M., S.M.D., C.E.S., J.G.S.); Department of Neurosurgery (S.V.N.), Department of Medicine (M.S.L., C.A.M.), and Cardiovascular Division (C.E.S.), Brigham and Women's Hospital, Boston, MA; and Howard Hughes Medical Institute, Chevy Chase, MD (C.E.S.). 2. From the Department of Neurosurgery (T.S.-S., X.F., G.W.H., K.J.P., S.M.C., K.J.Q., J.P.H., D.H.K.) and Division of Medical Genetics, Department of Internal Medicine (D.M.M.), The University of Texas Medical School at Houston; Department of Genetics, Harvard Medical School, Boston, MA (M.L.H., S.V.N., S.R.D., S.C.G., B.M., S.M.D., C.E.S., J.G.S.); Department of Neurosurgery (S.V.N.), Department of Medicine (M.S.L., C.A.M.), and Cardiovascular Division (C.E.S.), Brigham and Women's Hospital, Boston, MA; and Howard Hughes Medical Institute, Chevy Chase, MD (C.E.S.). Dong.H.Kim@uth.tmc.edu.
Abstract
BACKGROUND AND PURPOSE: A ruptured intracranial aneurysm (IA) is the leading cause of a subarachnoid hemorrhage. This study seeks to define a specific gene whose mutation leads to disease. METHODS: More than 500 IA probands and 100 affected families were enrolled and clinically characterized. Whole exome sequencing was performed on a large family, revealing a segregating THSD1 (thrombospondin type 1 domain containing protein 1) mutation. THSD1 was sequenced in other probands and controls. Thsd1 loss-of-function studies in zebrafish and mice were used for in vivo analyses and functional studies performed using an in vitro endothelial cell model. RESULTS: A nonsense mutation in THSD1 was identified that segregated with the 9 affected (3 suffered subarachnoid hemorrhage and 6 had unruptured IA) and was absent in 13 unaffected family members (LOD score 4.69). Targeted THSD1 sequencing identified mutations in 8 of 507 unrelated IA probands, including 3 who had suffered subarachnoid hemorrhage (1.6% [95% confidence interval, 0.8%-3.1%]). These THSD1 mutations/rare variants were highly enriched in our IA patient cohort relative to 89 040 chromosomes in Exome Aggregation Consortium (ExAC) database (P<0.0001). In zebrafish and mice, Thsd1 loss-of-function caused cerebral bleeding (which localized to the subarachnoid space in mice) and increased mortality. Mechanistically, THSD1 loss impaired endothelial cell focal adhesion to the basement membrane. These adhesion defects could be rescued by expression of wild-type THSD1 but not THSD1 mutants identified in IA patients. CONCLUSIONS: This report identifies THSD1 mutations in familial and sporadic IA patients and shows that THSD1 loss results in cerebral bleeding in 2 animal models. This finding provides new insight into IA and subarachnoid hemorrhage pathogenesis and provides new understanding of THSD1 function, which includes endothelial cell to extracellular matrix adhesion.
BACKGROUND AND PURPOSE: A ruptured intracranial aneurysm (IA) is the leading cause of a subarachnoid hemorrhage. This study seeks to define a specific gene whose mutation leads to disease. METHODS: More than 500 IA probands and 100 affected families were enrolled and clinically characterized. Whole exome sequencing was performed on a large family, revealing a segregating THSD1 (thrombospondin type 1 domain containing protein 1) mutation. THSD1 was sequenced in other probands and controls. Thsd1 loss-of-function studies in zebrafish and mice were used for in vivo analyses and functional studies performed using an in vitro endothelial cell model. RESULTS: A nonsense mutation in THSD1 was identified that segregated with the 9 affected (3 suffered subarachnoid hemorrhage and 6 had unruptured IA) and was absent in 13 unaffected family members (LOD score 4.69). Targeted THSD1 sequencing identified mutations in 8 of 507 unrelated IA probands, including 3 who had suffered subarachnoid hemorrhage (1.6% [95% confidence interval, 0.8%-3.1%]). These THSD1 mutations/rare variants were highly enriched in our IApatient cohort relative to 89 040 chromosomes in Exome Aggregation Consortium (ExAC) database (P<0.0001). In zebrafish and mice, Thsd1 loss-of-function caused cerebral bleeding (which localized to the subarachnoid space in mice) and increased mortality. Mechanistically, THSD1 loss impaired endothelial cell focal adhesion to the basement membrane. These adhesion defects could be rescued by expression of wild-type THSD1 but not THSD1 mutants identified in IApatients. CONCLUSIONS: This report identifies THSD1 mutations in familial and sporadic IApatients and shows that THSD1 loss results in cerebral bleeding in 2 animal models. This finding provides new insight into IA and subarachnoid hemorrhage pathogenesis and provides new understanding of THSD1 function, which includes endothelial cell to extracellular matrix adhesion.
Authors: A Ronkainen; J Hernesniemi; M Puranen; L Niemitukia; R Vanninen; M Ryynänen; H Kuivaniemi; G Tromp Journal: Lancet Date: 1997-02-08 Impact factor: 79.321
Authors: J E Bromberg; G J Rinkel; A Algra; P Greebe; C M van Duyn; D Hasan; M Limburg; H W ter Berg; E F Wijdicks; J van Gijn Journal: BMJ Date: 1995-07-29
Authors: Susan J Monkley; Vassiliki Kostourou; Lorraine Spence; Brian Petrich; Stacey Coleman; Mark H Ginsberg; Catrin A Pritchard; David R Critchley Journal: Dev Biol Date: 2010-11-26 Impact factor: 3.582
Authors: Zhen Xu; Yan-Ning Rui; Julien Balzeau; Miriam R Menezes; Airu Niu; John P Hagan; Dong H Kim Journal: Biochem Biophys Res Commun Date: 2017-05-30 Impact factor: 3.575
Authors: Tanyeri Barak; Emma Ristori; A Gulhan Ercan-Sencicek; Danielle F Miyagishima; Carol Nelson-Williams; Weilai Dong; Sheng Chih Jin; Andrew Prendergast; William Armero; Octavian Henegariu; E Zeynep Erson-Omay; Akdes Serin Harmancı; Mikhael Guy; Batur Gültekin; Deniz Kilic; Devendra K Rai; Nükte Goc; Stephanie Marie Aguilera; Burcu Gülez; Selin Altinok; Kent Ozcan; Yanki Yarman; Süleyman Coskun; Emily Sempou; Engin Deniz; Jared Hintzen; Andrew Cox; Elena Fomchenko; Su Woong Jung; Ali Kemal Ozturk; Angeliki Louvi; Kaya Bilgüvar; E Sander Connolly; Mustafa K Khokha; Kristopher T Kahle; Katsuhito Yasuno; Richard P Lifton; Ketu Mishra-Gorur; Stefania Nicoli; Murat Günel Journal: Nat Med Date: 2021-12-09 Impact factor: 87.241
Authors: Mark K Bakker; Suze Cobyte; Frederic A M Hennekam; Gabriel J E Rinkel; Jan H Veldink; Ynte M Ruigrok Journal: Eur J Hum Genet Date: 2022-03-01 Impact factor: 5.351